Compare ARK Genomic Revolution ETF (ARKG) vs iShares MSCI India ETF (INDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MSCI India ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.6, while iShares MSCI India ETF trades at $49.02. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | INDA | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $55.29 |
52-Week Low | $23.09 | $45.42 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
INDA, the iShares MSCI India ETF, trades at $49.30 with a slight 0.57% daily gain amid a predominantly bearish technical outlook. The ETF faces mixed sentiment with India's strong 7.8% GDP growth (CNBC, 2026-06-05) contrasting with sectoral challenges in IT and clean energy. Technical indicators show neutral oscillators but bearish moving averages, with all support and resistance levels clustered around $49.
The outlook remains cautious due to macroeconomic risks from Middle East conflicts and domestic sector pressures. However, India's position as the fastest-growing large economy and analyst price targets suggesting upside potential (Seeking Alpha, 2026-06-03) offer long-term opportunities amid near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →
